These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 35969778)

  • 1. Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8
    Chen J; Ye Z; Huang C; Qiu M; Song D; Li Y; Xu Q
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2207841119. PubMed ID: 35969778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria.
    Meulewaeter S; Aernout I; Deprez J; Engelen Y; De Velder M; Franceschini L; Breckpot K; Van Calenbergh S; Asselman C; Boucher K; Impens F; De Smedt SC; Verbeke R; Lentacker I
    J Control Release; 2024 Jun; 370():379-391. PubMed ID: 38697317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node macrophages drive innate immune responses to enhance the anti-tumor efficacy of mRNA vaccines.
    Kubara K; Yamazaki K; Miyazaki T; Kondo K; Kurotaki D; Tamura T; Suzuki Y
    Mol Ther; 2024 Mar; 32(3):704-721. PubMed ID: 38243602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of lymph nodes-targeting tumor vaccines by using the principle of DNA base complementary pairing to enhance anti-tumor cellular immune response.
    Zha Y; Fu L; Liu Z; Lin J; Huang L
    J Nanobiotechnology; 2024 May; 22(1):230. PubMed ID: 38720322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Cancer Vaccine Using In Vivo Click-Chemistry-Mediated Active Lymph Node Accumulation for Improved Immunotherapy.
    Qin H; Zhao R; Qin Y; Zhu J; Chen L; Di C; Han X; Cheng K; Zhang Y; Zhao Y; Shi J; Anderson GJ; Zhao Y; Nie G
    Adv Mater; 2021 May; 33(20):e2006007. PubMed ID: 33792097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of mRNA Vaccine with 1, 2-Diesters-Derived Lipids Elicits Fast Liver Clearance for Safe and Effective Cancer Immunotherapy.
    Xu Y; Hu Y; Xia H; Zhang S; Lei H; Yan B; Xiao ZX; Chen J; Pang J; Zha GF
    Adv Healthc Mater; 2024 Feb; 13(5):e2302691. PubMed ID: 37990414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection.
    Takanashi A; Pouton CW; Al-Wassiti H
    Mol Pharm; 2023 Aug; 20(8):3876-3885. PubMed ID: 37491979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice.
    Islam MA; Rice J; Reesor E; Zope H; Tao W; Lim M; Ding J; Chen Y; Aduluso D; Zetter BR; Farokhzad OC; Shi J
    Biomaterials; 2021 Jan; 266():120431. PubMed ID: 33099060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supramolecular Lipid Nanoparticles Based on Host-Guest Recognition: A New Generation Delivery System of mRNA Vaccines For Cancer Immunotherapy.
    Qi S; Zhang X; Yu X; Jin L; Yang K; Wang Y; Feng Y; Lei J; Mao Z; Yu G
    Adv Mater; 2024 Jun; 36(23):e2311574. PubMed ID: 38433564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-activated IL-2 mRNA delivered by lipid nanoparticles for cancer immunotherapy.
    Jiang Y; Zhang Y; Liu C; Liu J; Xue W; Wang Z; Li X
    J Control Release; 2024 Apr; 368():663-675. PubMed ID: 38492862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Mannosylated Lipid Nanoparticles for mRNA Cancer Vaccine with High Antigen Presentation Efficiency and Immunomodulatory Capability.
    Lei J; Qi S; Yu X; Gao X; Yang K; Zhang X; Cheng M; Bai B; Feng Y; Lu M; Wang Y; Li H; Yu G
    Angew Chem Int Ed Engl; 2024 Mar; 63(13):e202318515. PubMed ID: 38320193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-Encapsulated mRNAs Encoding Complex Fusion Proteins Potentiate Antitumor Immune Responses.
    Shuptrine CW; Chen Y; Miriyala J; Lenz K; Moffett D; Nguyen TA; Michaux J; Campbell K; Smith C; Morra M; Rivera-Molina Y; Murr N; Cooper S; McGuire A; Makani V; Oien N; Zugates JT; de Silva S; Schreiber TH; de Picciotto S; Fromm G
    Cancer Res; 2024 May; 84(10):1550-1559. PubMed ID: 38381555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-Responsive β-Glucans-Complexed mRNA in LNPs as an Oral Vaccine for Enhancing Cancer Immunotherapy.
    Luo PK; Ho HM; Chiang MC; Chu LA; Chuang YH; Lyu PC; Hu IC; Chang WA; Peng SY; Jayakumar J; Chen HL; Huang MH; Sung HW
    Adv Mater; 2024 Aug; 36(33):e2404830. PubMed ID: 38895941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mRNAs encoding self-DNA reactive cGAS enhance the immunogenicity of lipid nanoparticle vaccines.
    Zhivaki D; Gosselin EA; Sengupta D; Concepcion H; Arinze C; Chow J; Nikiforov A; Komoroski V; MacFarlane C; Sullivan C; Kagan JC
    mBio; 2023 Dec; 14(6):e0250623. PubMed ID: 37937842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-Trans-Retinoic Acid-Adjuvanted mRNA Vaccine Induces Mucosal Anti-Tumor Immune Responses for Treating Colorectal Cancer.
    Li W; Li Y; Li J; Meng J; Jiang Z; Yang C; Wen Y; Liu S; Cheng X; Mi S; Zhao Y; Miao L; Lu X
    Adv Sci (Weinh); 2024 Jun; 11(22):e2309770. PubMed ID: 38528670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic Delivery of Antigen-Loaded Magnetic Liposomes for Active Lymph Node Targeting and Enhanced Anti-Tumor Immunity.
    Sheng J; Liu Y; Ding H; Wu L; Liu L; Si G; Shen Y; Yang F; Gu N
    Adv Healthc Mater; 2023 Dec; 12(32):e2301232. PubMed ID: 37709487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL7 increases targeted lipid nanoparticle-mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation.
    Tilsed CM; Sadiq BA; Papp TE; Areesawangkit P; Kimura K; Noguera-Ortega E; Scholler J; Cerda N; Aghajanian H; Bot A; Mui B; Tam Y; Weissman D; June CH; Albelda SM; Parhiz H
    Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2319856121. PubMed ID: 38513098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimuli-Responsive mRNA Vaccines to Induce Robust CD8
    Dong L; Deng X; Li Y; Zhu X; Shu M; Chen J; Luo H; An K; Cheng M; Zhang P; Tan W
    J Am Chem Soc; 2024 Jul; 146(28):19218-19228. PubMed ID: 38955767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionizable Lipid Nanoparticle-Mediated TRAIL mRNA Delivery in the Tumor Microenvironment to Inhibit Colon Cancer Progression.
    da Silva WN; Carvalho Costa PA; Scalzo Júnior SRA; Ferreira HAS; Prazeres PHDM; Campos CLV; Rodrigues Alves MT; Alves da Silva NJ; de Castro Santos AL; Guimarães LC; Chen Ferris ME; Thatte A; Hamilton A; Bicalho KA; Lobo AO; Santiago HDC; da Silva Barcelos L; Figueiredo MM; Teixeira MM; Vasconcelos Costa V; Mitchell MJ; Frézard F; Pires Goulart Guimaraes P
    Int J Nanomedicine; 2024; 19():2655-2673. PubMed ID: 38500680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid mRNA Nano Vaccine Potentiates Antigenic Peptide Presentation and Dendritic Cell Maturation for Effective Cancer Vaccine Therapy and Enhances Response to Immune Checkpoint Blockade.
    Shi L; Yang J; Nie Y; Huang Y; Gu H
    Adv Healthc Mater; 2023 Dec; 12(32):e2301261. PubMed ID: 37822133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.